172 related articles for article (PubMed ID: 6894381)
21. [The histoenzymological and ultrastructural changes in the gastric mucosa in peptic ulcer after treatment with pirenzepine and histamine H2-receptor blockaders].
Degtiareva II; Kharchenko NV; Lodianaia EV; Zukheĭr Kh; Tokar' DV; Nevstruev VP; Piletskiĭ AM
Lik Sprava; 1995; (1-2):48-51. PubMed ID: 7483543
[TBL] [Abstract][Full Text] [Related]
22. [Histamine-acetazolamide-carbonic anhydrase interaction in gastric mucosa].
Puşcaş I; Chiu A; Buzas G
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(4):353-4. PubMed ID: 6113648
[No Abstract] [Full Text] [Related]
23. [Carbonic anhydrase inhibitors in the treatment of gastro-duodenal ulcer].
Puscas D; Paun I; Ursea R; Lenghel N; Dinga C A
G E N; 1975; 30(1-2):93-100. PubMed ID: 829086
[TBL] [Abstract][Full Text] [Related]
24. [Carbonic anhydrase activity of the gastric mucosa in experimental ulcer].
Dobrescu D; Cicotti A
Arch Fr Mal App Dig; 1970 Dec; 59(12):809-12. PubMed ID: 4993616
[No Abstract] [Full Text] [Related]
25. [Conservative therapy of peptic ulcer].
Clémençon GH
Schweiz Med Wochenschr; 1980 Oct; 110(41):1474-82. PubMed ID: 6106967
[TBL] [Abstract][Full Text] [Related]
26. Effect of verapamil on purified bovine carbonic anhydrase. An in vitro study.
Puscas I; Búzás G; Sturzu L; Vălean S
Arzneimittelforschung; 1984; 34(9):946-7. PubMed ID: 6542373
[TBL] [Abstract][Full Text] [Related]
27. [Pirenzepina as an inhibitor of gastric secretion (experimental research)].
Di Mezza G; Turtur A; Visone C; Sannino A; Luppino E; Nutile T; Perri T; Montanino C
Arch Sci Med (Torino); 1980; 137(1):45-60. PubMed ID: 6893926
[TBL] [Abstract][Full Text] [Related]
28. Treatment of duodenal ulcers with ethoxzolamide, an inhibitor of gastric mucosa carbonic anhydrase.
Puscas I; Buzas G
Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):97-9. PubMed ID: 3957499
[TBL] [Abstract][Full Text] [Related]
29. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
30. Studies on acid protease fractions and gastric mucosal atrophy. 3. Special reference to peptic ulcers.
Yamamoto S; Arima T; Tomoda J; Kita S; Nagashima H
Gastroenterol Jpn; 1980; 15(6):609-15. PubMed ID: 6778755
[TBL] [Abstract][Full Text] [Related]
31. Association between genetic polymorphisms in the cyclooxygenase-1 gene promoter and peptic ulcers in Japan.
Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Nakamura M; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
Int J Mol Med; 2007 Sep; 20(3):373-8. PubMed ID: 17671743
[TBL] [Abstract][Full Text] [Related]
32. [Retrospective study of the evaluation of peptic ulcer recurrence after 4 weeks of pirenzepin (Gastrozepin) treatment].
Krempler F; Sandhofer F; Kalk A
Wien Med Wochenschr; 1983 Nov; 133(21):553-7. PubMed ID: 6689235
[TBL] [Abstract][Full Text] [Related]
33. [Gastrozepin--a new anti-ulcer agent (a review of the literature and the authors' own data)].
Grigor'ev IIa; Zhivodereov VM; Khar'kovskiĭ NN
Ter Arkh; 1984; 56(2):43-5. PubMed ID: 6369608
[No Abstract] [Full Text] [Related]
34. [The mechanism of action of pirenzepin (gastrozepin), a new inhibitor of secretion].
Heller G; Karn U; Neubauer M; Althoff PH; Schöffling K
Verh Dtsch Ges Inn Med; 1978; (84):991-4. PubMed ID: 742169
[No Abstract] [Full Text] [Related]
35. A new concept regarding the mechanism of action of omeprazole.
Puscas I; Coltau M; Baican M; Domuta G
Int J Clin Pharmacol Ther; 1999 Jun; 37(6):286-93. PubMed ID: 10395120
[TBL] [Abstract][Full Text] [Related]
36. Effects of cimetidine and pirenzepine on peroperative electrical vagal stimulation of gastric acid secretion.
Fritsch WP; Schacht U; Scholten T; Hengels KJ; Mueller J; Strasser K
Scand J Gastroenterol Suppl; 1980; 66():95-100. PubMed ID: 6941381
[TBL] [Abstract][Full Text] [Related]
37. The role of mucosal carbonic anhydrase in the protection of gastric mucosa against luminal H+.
Kivilaakso E; Silen W
Scand J Gastroenterol Suppl; 1981; 67():219-21. PubMed ID: 6787695
[TBL] [Abstract][Full Text] [Related]
38. Actions of pirenzepine-dihydrochloride (LS-519 Cl) on gastric juice secretion, gastric motility and experimental gastric ulcer.
Matsuo Y; Seki A
Arzneimittelforschung; 1979; 29(7):1028-35. PubMed ID: 582994
[No Abstract] [Full Text] [Related]
39. Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease.
Wodziński MA; Bardhan KD; Reilly JT; Cooper P; Preston FE
Gut; 1993 Oct; 34(10):1310-4. PubMed ID: 8244093
[TBL] [Abstract][Full Text] [Related]
40. [Pathogenesis, diagnosis and therapy of ulcer disease. Therapy. 3: Pharmacologic basis and therapy with pirenzepine].
Med Welt; 1983 Dec; 34(48):14-7. PubMed ID: 6689191
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
